PDL BioPharma, Inc. (NASDAQ:PDLI) on Nov. 10 reported financial results for the third quarter and nine months ended Sept. 30, 2014. Total revenues for the third quarter of 2014 increased approx. 64% to $164.6 million from $100.2 million in the third quarter of 2013. Total revenues for the first nine months of 2014 increased 35% to $464.2 million, compared with $344.3 million for the first nine months of 2013. Net income in the third quarter of 2014 was $102.2 million, or $0.61 per diluted share, as compared with net income in the third quarter of 2013 of $56.2 million, or $0.36 per diluted share. Net income for the first nine months of 2014 was $267.2 million, or $1.62 per diluted share. PDL BioPharma, Inc. (NASDAQ:PDLI) belongs to Healthcare sector. Its net profit margin is 55.70% and weekly performance is -4.86%. On last trading day company shares ended up $8.02. PDL BioPharma, Inc. (NASDAQ:PDLI) distance from 50-day simple moving average (SMA50) is -3.25%.

Alcoa Inc. (NSYE:AA), a $19.24 billion market cap company, is one of the world’s largest producers of aluminum. This integrated producer company focuses on several end markets, including packaging, automobiles, aircraft, and construction. Airline fundamentals are improving with a projected air travel demand rising roughly 10% in the aerospace market. Additionally, Alcoa is focusing in the auto industry, where vehicle sales are higher than before. Aluminum represents the second largest-volume component material in automotive vehicles and is expected to double by 2025. Alcoa Inc. (NYSE:AA) shares advanced 2.61% in last trading session and ended the day at $16.88. AA Gross Margin is 18.40% and its return on assets is -6.70%. Alcoa Inc. (NYSE:AA) quarterly performance is 4.20%.

eMagin Corp. (NASDAQ:EMAN) is scheduled to be releasing its earnings data on Thursday, November 13th. On 12 November, eMagin Corp. (NYSEMKT:EMAN) shares fell -1.64% and was closed at $2.63. EMAN EPS growth in last 5 year was -35.80%. eMagin Corp. (NYSEMKT:EMAN) year to date (YTD) performance is -7.07%.

Amedisys Inc. (NASDAQ:AMED) last released its earnings data on Wednesday, October 29th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.15 by $0.11. The company had revenue of $300.30 million for the quarter, compared to the consensus estimate of $299.26 million. During the same quarter in the previous year, the company posted ($0.01) earnings per share. The company’s revenue for the quarter was down .3% on a year-over-year basis. Analysts expect that Amedisys will post $0.72 EPS for the current fiscal year. Amedisys Inc. (NASDAQ:AMED) ended the last trading day at $25.11. Company weekly volatility is calculated as 2.97% and price to cash ratio as 152.39. Amedisys Inc. (NASDAQ:AMED) showed a weekly performance of -1.68%.

Aerospace manufacturer CPI Aerostructures Inc. (NYSEMKT:CVU) Tuesday posted an increase in third-quarter revenue versus the 2013 period but a decline in net income as the cost of sales, such as material and labor expenses, increased. CPI Aerostructures Inc. (NYSEMKT:CVU) shares advanced 2.62% in last trading session and ended the day at $10.56. CVU Gross Margin is -71.60% and its return on assets is -19.10%. CPI Aerostructures Inc. (NYSEMKT:CVU) quarterly performance is -4.78%.

Sign up for our next MicroCap Runner ahead of the crowd!
We hate spam. No Hidden Fees. Unsubscribe Anytime.
Shining on Major News: PDL BioPharma, Inc. (NASDAQ:PDLI), Alcoa Inc. (NYSE:AA), eMagin Corp. (NYSEMKT:EMAN), Amedisys Inc. (NASDAQ:AMED), CPI Aerostructures Inc. (NYSEMKT:CVU)
Click to comment
To Top